Related Experiment Videos
Physiological distribution of digoxin in human heart
British Medical Journal
|December 28, 1974
Summary
Digoxin levels in human heart tissue were studied. Myocardial ischemia affects tissue distribution, suggesting plasma levels may not accurately reflect total heart levels, especially with diffuse abnormalities.
Area of Science:
- Cardiology
- Pharmacology
- Cell Biology
Background:
- Digoxin is a cardiac glycoside used to treat heart failure and arrhythmias.
- Understanding digoxin distribution in heart tissue is crucial for optimizing therapeutic efficacy and minimizing toxicity.
- Myocardial abnormalities can influence drug distribution and response.
Purpose of the Study:
- To investigate the cellular and subcellular distribution of digoxin in human heart tissue.
- To determine how myocardial histological abnormalities affect digoxin distribution.
- To assess the relationship between plasma digoxin concentrations and myocardial digoxin levels.
Main Methods:
- Human heart tissue samples were obtained from cardiac transplantation recipients.
- Digoxin levels were analyzed at both cellular and subcellular levels.
- Histological examination of myocardial tissue was performed to identify abnormalities.
Main Results:
- In cases of diffuse myocardial histological abnormalities, total tissue digoxin concentration was decreased.
- Subcellular distribution of digoxin remained uniform, suggesting consistent binding to potential receptor sites.
- Focal histological abnormalities did not alter the uniform distribution of digoxin within the tissue.
Conclusions:
- Myocardial ischemia, particularly with diffuse abnormalities, can lead to decreased tissue digoxin levels.
- Plasma digoxin concentrations may not accurately represent total myocardial digoxin levels in patients with myocardial ischemia.
- The findings highlight the importance of considering myocardial health when interpreting digoxin levels.